High doses of erythropoiesis-stimulating agents were associated with an increased risk for cancer in patients on dialysis, but the real risk attributed to these medications remains unclear.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/do-esas-anemia-raise-cancer-risk-dialysis-patients-2026a10009nf?src=rss
Author :
Publish date : 2026-03-30 13:19:00
Copyright for syndicated content belongs to the linked Source.
